Evercore ISI Issues Positive Forecast for W. P. Carey (NYSE:WPC) Stock Price
W. P. Carey (NYSE:WPC – Get Free Report) had its price objective increased by equities research analysts at Evercore ISI from $60.00 to $64.00 in a note issued to investors on Wednesday,Benzinga ...
Hosted on MSN18h
Apple’s 16e “can add $14B in iPhone sales,” Says Evercore Analyst
Evercore ISI analyst Amit Daryanani believes that Apple’s ($AAPL) iPhone 16e launch could “add ~$14B in iPhone sales revenue.
Evercore ISI Lowers Magna International (NYSE:MGA) Price Target to $45.00
Magna International (NYSE:MGA – Get Free Report) (TSE:MG) had its price target reduced by stock analysts at Evercore ISI from ...
Evercore ISI Reaffirms Their Hold Rating on Deere (DE)
Evercore ISI analyst David Raso maintained a Hold rating on Deere (DE – Research Report) yesterday and set a price target of $455.00. The ...
Evercore ISI Keeps Their Hold Rating on Entergy (ETR)
Evercore ISI analyst Michael Lonegan maintained a Hold rating on Entergy (ETR – Research Report) yesterday and set a price target of $86.00.
Apple Inc. (AAPL) Gains Bullish Outlook as Evercore ISI Highlights iPhone SE Launch
In this article, we are going to take a look at where Apple Inc. (NASDAQ:AAPL) stands against the other AI stocks. Tiger ...
Evercore adds Wendy’s to outperform list ahead of investor day
Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6 ...
Investing6d
CRISPR Therapeutics stock rises following analyst upgrade
Evercore ISI analyst Liisa Bayko raised the price target for CRISPR Therapeutics from $60.00 to $99.00. Bayko's optimism is driven by upcoming catalysts that could mark a new chapter for the company.